Gilead Sciences, Inc. (GILD)
Last Price$88.4(4.0%)
Market Cap$95.9B
GILD overview
Crunching data... Almost there!
1W (8.5%)
1M 3.0%
6M 34.8%
YTD 9.6%
1Y 22.7%
3Y 49.0%
5Y 66.8%
10Y 22.2%
Share Price
Intrinsic Value
Drawdown
Total Return
vs SP500
vs NASDAQ
GILD key stats
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Crunching data... Almost there!
GILD Intrinsic value
GILD Intrinsic value overview
GILD Historical intrinsic value
GILD Financials
GILD Income statement
Crunching data... Almost there!
GILD Balance sheet
Crunching data... Almost there!
GILD Cash flow statement
Crunching data... Almost there!
GILD Financial ratios
GILD Growth
Crunching data... Almost there!
GILD Returns on capital
Crunching data... Almost there!
Compare with peers: operational metrics
Growth & profitability
Solvency & returns
Crunching data... Almost there!
Wall Street estimates
Price target
Crunching data... Almost there!
Crunching data... Almost there!
EPS Surprises
Crunching data... Almost there!
Looking for the most undervalued companies?
Here's our top picks.
Crunching data... Almost there!
Discover more GILD fundamentals
Stock picking tips.
Ultimate guide 2024
Discover the secrets to successful stock picking in 2024!
We asked 1,000 top investors for their insights on the best stocks, investment strategies, and market trends.
FAQ
What is the Intrinsic Value of Gilead Sciences, Inc. (GILD) stock?
As of today, intrinsic value of Gilead Sciences, Inc. is $148.2.
Is Gilead Sciences, Inc. (GILD) stock undervalued or overvalued?
As of today, Gilead Sciences, Inc. is undervalued by 40.3%, compared to the current market share price of $88.4.
What is Gilead Sciences, Inc. (GILD) stock rating?
As of today, Gilead Sciences, Inc. has a stock rating of 6 (out of 10), which is considered Good.
is Gilead Sciences, Inc. (GILD) a good stock to buy?
As of today, Gilead Sciences, Inc. has a Good stock rating, which is 40.3% undervalued. According to Value Sense backtesting, stocks with similar profile tend to outperform the market by 3.2%.